
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $258.4K | $43.1K | $32K | $58.8M | $86.3M | |
Revenue Growth (YoY) | -96.65% | -83.32% | -25.72% | 183479.3% | 46.77% | |
Cost of Revenues | $503K | $88.5K | $18.9K | $40.7M | $61.7M | |
Gross Profit | -$244.7K | -$45.4K | $13.1K | $18M | $24.6M | |
Gross Profit Margin | -94.69% | -105.2% | 40.94% | 30.68% | 28.51% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.7M | $5.1M | $26.6M | $55.9M | $56.7M | |
Other Inc / (Exp) | $257.9K | $18.1K | $178.3K | $1.2M | $400K | |
Operating Expenses | $8.7M | $5.1M | $26.6M | $55.9M | $56.7M | |
Operating Income | -$9M | -$5.2M | -$26.6M | -$37.8M | -$32.1M | |
Net Interest Expenses | $514K | $560.4K | $589K | $3.1M | $4.1M | |
EBT. Incl. Unusual Items | -$9.2M | -$5.7M | -$27M | -$39.7M | -$35.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$9.2M | -$5.7M | -$27M | -$39.7M | -$35.8M | |
Minority Interest in Earnings | -- | -- | -$35.4K | -- | -- | |
Net Income to Common Excl Extra Items | -$9.2M | -$5.7M | -$27.1M | -$39.7M | -$35.8M | |
Basic EPS (Cont. Ops) | -$0.15 | -$0.09 | -$0.40 | -$0.45 | -$0.36 | |
Diluted EPS (Cont. Ops) | -$0.15 | -$0.09 | -$0.40 | -$0.45 | -$0.36 | |
Weighted Average Basic Share | $62.8M | $64.9M | $79.5M | $88.4M | $99.8M | |
Weighted Average Diluted Share | $62.8M | $64.9M | $79.5M | $88.4M | $99.8M | |
EBITDA | -$8.6M | -$5.1M | -$25.6M | -$33.7M | -$27.6M | |
EBIT | -$8.7M | -$5.2M | -$26.4M | -$36.6M | -$31.7M | |
Revenue (Reported) | $258.4K | $43.1K | $32K | $58.8M | $86.3M | |
Operating Income (Reported) | -$9M | -$5.2M | -$26.6M | -$37.8M | -$32.1M | |
Operating Income (Adjusted) | -$8.7M | -$5.2M | -$26.4M | -$36.6M | -$31.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $100.2K | $7K | $10K | $19M | $20.1M | |
Revenue Growth (YoY) | -91.39% | -93.04% | 43.81% | 189204.95% | 5.99% | |
Cost of Revenues | $82.5K | $5.6K | $1.5K | $13.4M | $14.4M | |
Gross Profit | $17.7K | $1.3K | $8.6K | $5.6M | $5.7M | |
Gross Profit Margin | 17.64% | 19.09% | 85.36% | 29.39% | 28.4% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $867.7K | $11.9M | $7.2M | $14.5M | $13.4M | |
Other Inc / (Exp) | -- | $178.3K | -- | -- | -- | |
Operating Expenses | $867.7K | $11.9M | $7.2M | $14.5M | $13.4M | |
Operating Income | -$850K | -$11.9M | -$7.2M | -$8.9M | -$7.7M | |
Net Interest Expenses | $136.9K | $90.5K | $730.6K | $787.9K | $1.3M | |
EBT. Incl. Unusual Items | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Minority Interest in Earnings | -- | -$35.4K | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Basic EPS (Cont. Ops) | -$0.02 | -$0.23 | -$0.10 | -$0.10 | -$0.09 | |
Diluted EPS (Cont. Ops) | -$0.02 | -$0.23 | -$0.10 | -$0.10 | -$0.09 | |
Weighted Average Basic Share | $64.6M | $72.8M | $83M | $95.1M | $103.5M | |
Weighted Average Diluted Share | $64.6M | $72.8M | $83M | $95.1M | $103.5M | |
EBITDA | -$829.2K | -$11.7M | -$6.7M | -$7.8M | -$6.7M | |
EBIT | -$850K | -$11.8M | -$7.2M | -$8.9M | -$7.7M | |
Revenue (Reported) | $100.2K | $7K | $10K | $19M | $20.1M | |
Operating Income (Reported) | -$850K | -$11.9M | -$7.2M | -$8.9M | -$7.7M | |
Operating Income (Adjusted) | -$850K | -$11.8M | -$7.2M | -$8.9M | -$7.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6.5M | -- | $35.1K | $77.8M | $87.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $5.3M | -- | $14.7K | $54.1M | $62.7M | |
Gross Profit | $1.2M | -$61.7K | $20.3K | $23.6M | $24.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $7.5M | $16.2M | $35.6M | $63.1M | $55.7M | |
Other Inc / (Exp) | -$1.8M | $196.3K | -- | $1.2M | -- | |
Operating Expenses | $9M | $16.2M | $21.9M | $63.1M | $55.7M | |
Operating Income | -$7.8M | -$16.3M | -$21.9M | -$39.5M | -$30.9M | |
Net Interest Expenses | $433.3K | $514K | $1.2M | $3.2M | $4.6M | |
EBT. Incl. Unusual Items | -$10M | -$16.6M | -$23.1M | -$41.4M | -$35.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$10M | -$16.6M | -$23.1M | -$41.4M | -$35.1M | |
Minority Interest in Earnings | -- | -$35.4K | -$35.4K | -- | -- | |
Net Income to Common Excl Extra Items | -$10M | -$16.6M | -$23.2M | -$41.4M | -$35.1M | |
Basic EPS (Cont. Ops) | -$0.19 | -$0.30 | -$0.29 | -$0.46 | -$0.36 | |
Diluted EPS (Cont. Ops) | -$0.19 | -$0.30 | -$0.29 | -$0.46 | -$0.36 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$8.2M | -$16M | -$20.6M | -$34.8M | -$26.5M | |
EBIT | -$9.6M | -$16.1M | -$21.9M | -$38.3M | -$30.5M | |
Revenue (Reported) | $6.5M | -- | $35.1K | $77.8M | $87.4M | |
Operating Income (Reported) | -$7.8M | -$16.3M | -$21.9M | -$39.5M | -$30.9M | |
Operating Income (Adjusted) | -$9.6M | -$16.1M | -$21.9M | -$38.3M | -$30.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $100.2K | $7K | $10K | $19M | $20.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $82.5K | $5.6K | $1.5K | $13.4M | $14.4M | |
Gross Profit | $17.7K | $1.3K | $8.6K | $5.6M | $5.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $867.7K | $11.9M | $7.2M | $14.5M | $13.4M | |
Other Inc / (Exp) | -- | $178.3K | -- | -- | -- | |
Operating Expenses | $867.7K | $11.9M | $7.2M | $14.5M | $13.4M | |
Operating Income | -$850K | -$11.9M | -$7.2M | -$8.9M | -$7.7M | |
Net Interest Expenses | $136.9K | $90.5K | $730.6K | $787.9K | $1.3M | |
EBT. Incl. Unusual Items | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Minority Interest in Earnings | -- | -$35.4K | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Basic EPS (Cont. Ops) | -$0.02 | -$0.23 | -$0.10 | -$0.10 | -$0.09 | |
Diluted EPS (Cont. Ops) | -$0.02 | -$0.23 | -$0.10 | -$0.10 | -$0.09 | |
Weighted Average Basic Share | $64.6M | $72.8M | $83M | $95.1M | $103.5M | |
Weighted Average Diluted Share | $64.6M | $72.8M | $83M | $95.1M | $103.5M | |
EBITDA | -$829.2K | -$11.7M | -$6.7M | -$7.8M | -$6.7M | |
EBIT | -$850K | -$11.8M | -$7.2M | -$8.9M | -$7.7M | |
Revenue (Reported) | $100.2K | $7K | $10K | $19M | $20.1M | |
Operating Income (Reported) | -$850K | -$11.9M | -$7.2M | -$8.9M | -$7.7M | |
Operating Income (Adjusted) | -$850K | -$11.8M | -$7.2M | -$8.9M | -$7.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.3M | $10.4M | $6.7M | $16.8M | $12.6M | |
Short Term Investments | -- | -- | $7.4M | -- | -- | |
Accounts Receivable, Net | $1.5K | -- | -- | $3.4M | $2.4M | |
Inventory | $918.7K | $918.7K | $1.9M | $3.4M | $3.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $41K | $311.6K | $721.7K | $1.3M | |
Total Current Assets | $3.2M | $11.4M | $16.3M | $27.3M | $20.4M | |
Property Plant And Equipment | $67.7K | $25.7K | $23.3M | $21.7M | $21.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $16.2M | $16.2M | |
Other Intangibles | $403.1K | $540K | $662.8K | $8.1M | $5.2M | |
Other Long-Term Assets | $2.2K | $2.2K | $2.9M | $3.1M | $3.1M | |
Total Assets | $3.7M | $12M | $43.2M | $76.3M | $65.9M | |
Accounts Payable | $1M | $996.7K | $1.9M | $12.4M | $13.2M | |
Accrued Expenses | $358.6K | $32.6K | -- | -- | -- | |
Current Portion Of Long-Term Debt | $344K | $404.7K | $1.7M | $6.9M | $8.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | $1.1M | $1.9M | $2.4M | |
Other Current Liabilities | $500K | $1.2M | $2.6M | $800K | $800K | |
Total Current Liabilities | $2.2M | $2.6M | $7.4M | $24.2M | $26.1M | |
Long-Term Debt | $6.5M | $6.8M | $4.9M | $6.8M | $8.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $12.6M | $12.1M | $35M | $60.1M | $56.8M | |
Common Stock | $37.7M | $74.2M | $114.3M | $162M | $190.8M | |
Other Common Equity Adj | -- | -- | -$62.2K | -- | -- | |
Common Equity | -$12.2M | -$3.4M | $7.9M | $16.2M | -$1.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$35.4K | -$35.4K | -- | -- | -- | |
Total Equity | -$8.9M | -$110.7K | $8.1M | $16.2M | $9.1M | |
Total Liabilities and Equity | $3.7M | $12M | $43.2M | $76.3M | $65.9M | |
Cash and Short Terms | $2.3M | $10.4M | $14.1M | $16.8M | $12.6M | |
Total Debt | $6.9M | $7.2M | $6.6M | $13.7M | $16.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $27.6M | $14.5M | $14.1M | $9.4M | |
Short Term Investments | -- | -- | $3.9M | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | $3.9M | $2.8M | |
Inventory | -- | $918.7K | $2.1M | $3.8M | $3.7M | |
Prepaid Expenses | -- | $1.4M | -- | -- | -- | |
Other Current Assets | -- | -- | $132.2K | $630.1K | $2M | |
Total Current Assets | -- | $29.9M | $20.6M | $25.5M | $18.3M | |
Property Plant And Equipment | -- | $207.2K | $22.8M | $21.8M | $20.9M | |
Long-Term Investments | -- | -- | $3.7M | -- | -- | |
Goodwill | -- | -- | -- | $16.2M | $16.2M | |
Other Intangibles | -- | $576.2K | $682.1K | $7.6M | $4.8M | |
Other Long-Term Assets | -- | $2.2K | $1.4M | $3.1M | $3.1M | |
Total Assets | -- | $30.7M | $49.2M | $74.2M | $63.2M | |
Accounts Payable | -- | -- | -- | $12.5M | $11.8M | |
Accrued Expenses | -- | -- | -- | -- | $215.3K | |
Current Portion Of Long-Term Debt | -- | $405K | $1.7M | $6.5M | $8.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | $1.6M | $2.2M | $2.4M | |
Other Current Liabilities | -- | $1.7M | $2.6M | $800K | $800K | |
Total Current Liabilities | -- | $4.7M | $8.1M | $24.3M | $28.6M | |
Long-Term Debt | -- | $6.6M | $10.1M | $10.3M | $8.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $13.2M | $40.4M | $60.7M | $58.9M | |
Common Stock | -- | $108.4M | $122.8M | $169M | $195.3M | |
Other Common Equity Adj | -- | -- | -$4.7K | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | $1.4M | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $17.5M | $8.7M | $13.5M | $4.3M | |
Total Liabilities and Equity | -- | $30.7M | $49.2M | $74.2M | $63.2M | |
Cash and Short Terms | -- | $27.6M | $18.4M | $14.1M | $9.4M | |
Total Debt | -- | $7M | $11.8M | $16.8M | $16.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9.2M | -$5.7M | -$27M | -$39.7M | -$35.8M | |
Depreciation & Amoritzation | $106.3K | $84.3K | $883.2K | $2.9M | $4.1M | |
Stock-Based Compensation | $5.1M | $1.5M | $14M | $18M | $13.5M | |
Change in Accounts Receivable | $418K | -- | -- | -$863.2K | $969.7K | |
Change in Inventories | $325.4K | -- | -$1M | $283.9K | -$359.6K | |
Cash From Operations | -$3.1M | -$4.6M | -$13.8M | -$13M | -$18.3M | |
Capital Expenditures | $109.9K | $179.2K | $620.3K | -- | $981.4K | |
Cash Acquisitions | -- | -- | -- | -$4.2M | -$750K | |
Cash From Investing | -$109.9K | -$179.2K | -$8.1M | $3.2M | -$1.7M | |
Dividends Paid (Ex Special Dividend) | -$130.2K | -$129.5K | -$38.1K | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.7M | $228.2K | -- | $16.9M | $500K | |
Long-Term Debt Repaid | -- | -$343.8K | -$446K | -$3.4M | -$2.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$2.5M | -$531K | -$88.4K | |
Cash From Financing | $3.7M | $12.9M | $20.9M | $22.7M | $13.1M | |
Beginning Cash (CF) | $1.9M | $2.3M | $10.4M | $9.5M | $22.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $435.1K | $8.1M | -$964.7K | $13M | -$6.9M | |
Ending Cash (CF) | $2.3M | $10.4M | $9.5M | $22.4M | $15.5M | |
Levered Free Cash Flow | -$3.2M | -$4.8M | -$14.5M | -$13M | -$19.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Depreciation & Amoritzation | $20.8K | $21.9K | $497.4K | $1.1M | $1M | |
Stock-Based Compensation | $187.4K | $8.8M | $3M | $3.3M | $3M | |
Change in Accounts Receivable | -- | -- | -- | -$547K | -$396K | |
Change in Inventories | -- | -- | -$178.8K | -$352K | $105.1K | |
Cash From Operations | -$764.1K | -$3.4M | -$4.1M | -$6.1M | -$4.3M | |
Capital Expenditures | $54.6K | $239.6K | $33.9K | $53.6K | $413.4K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$54.6K | -$239.6K | -$169.9K | -$53.7K | -$413.4K | |
Dividends Paid (Ex Special Dividend) | -$32.6K | -$21.2K | -- | -- | -$212.7K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $228.2K | -- | $10.4M | -- | -- | |
Long-Term Debt Repaid | -- | -$840 | -$890 | -$60.4K | -$121.9K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$2.5M | -- | -$73.1K | -$9.2K | |
Cash From Financing | $950.2K | $20.7M | $10.3M | $3.5M | $1.5M | |
Beginning Cash (CF) | $2.3M | $10.4M | $9.5M | $22.4M | $15.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $131.4K | $17.1M | $6.1M | -$2.6M | -$3.2M | |
Ending Cash (CF) | $2.4M | $27.6M | $15.5M | $19.8M | $12.3M | |
Levered Free Cash Flow | -$818.7K | -$3.6M | -$4.2M | -$6.2M | -$4.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$10M | -$16.6M | -$23.1M | -$41.4M | -$35.1M | |
Depreciation & Amoritzation | $1.4M | $85.4K | $1.4M | $3.4M | $4M | |
Stock-Based Compensation | $1.2M | $10M | $8.2M | $18.3M | $13.2M | |
Change in Accounts Receivable | -- | -- | -- | -$1.4M | $1.1M | |
Change in Inventories | -- | -- | -$1.2M | $110.7K | $97.4K | |
Cash From Operations | -$8.5M | -$7.2M | -$14.6M | -$15M | -$16.5M | |
Capital Expenditures | $86.1K | $364.2K | $414.6K | $19.8K | $1.3M | |
Cash Acquisitions | -- | -- | -- | -$4.2M | -$750K | |
Cash From Investing | -$86.1K | -$364.2K | -$8M | $3.4M | -$2.1M | |
Dividends Paid (Ex Special Dividend) | -$130.2K | -$118.1K | -$16.8K | -- | -$212.7K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $6.4M | -- | $10.4M | $6.5M | $500K | |
Long-Term Debt Repaid | -$70.2K | -$344.7K | -$446.1K | -$3.5M | -$2.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$604.1K | -$24.5K | |
Cash From Financing | $7M | $32.7M | $10.5M | $15.9M | $11.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.6M | $25.1M | -$12M | $4.3M | -$7.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$8.6M | -$7.6M | -$15M | -$15M | -$17.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$986.9K | -$11.9M | -$8M | -$9.7M | -$9.1M | |
Depreciation & Amoritzation | $20.8K | $21.9K | $497.4K | $1.1M | $1M | |
Stock-Based Compensation | $187.4K | $8.8M | $3M | $3.3M | $3M | |
Change in Accounts Receivable | -- | -- | -- | -$547K | -$396K | |
Change in Inventories | -- | -- | -$178.8K | -$352K | $105.1K | |
Cash From Operations | -$764.1K | -$3.4M | -$4.1M | -$6.1M | -$4.3M | |
Capital Expenditures | $54.6K | $239.6K | $33.9K | $53.6K | $413.4K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$54.6K | -$239.6K | -$169.9K | -$53.7K | -$413.4K | |
Dividends Paid (Ex Special Dividend) | -$32.6K | -$21.2K | -- | -- | -$212.7K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $228.2K | -- | $10.4M | -- | -- | |
Long-Term Debt Repaid | -- | -$840 | -$890 | -$60.4K | -$121.9K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$2.5M | -- | -$73.1K | -$9.2K | |
Cash From Financing | $950.2K | $20.7M | $10.3M | $3.5M | $1.5M | |
Beginning Cash (CF) | $2.3M | $10.4M | $9.5M | $22.4M | $15.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $131.4K | $17.1M | $6.1M | -$2.6M | -$3.2M | |
Ending Cash (CF) | $2.4M | $27.6M | $15.5M | $19.8M | $12.3M | |
Levered Free Cash Flow | -$818.7K | -$3.6M | -$4.2M | -$6.2M | -$4.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.